Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Studies

Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Lutetium-177-CC49

Ruby F. Meredith, Edward E. Partridge, Ronald D. Alvarez, M.B. Khazaeli, Gene Plott, Charles D. Russell, Richard H. Wheeler, Tiepu Liu, William E. Grizzle, Jeffrey Schlom and Albert F. LoBuglio
Journal of Nuclear Medicine September 1996, 37 (9) 1491-1496;
Ruby F. Meredith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward E. Partridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald D. Alvarez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.B. Khazaeli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gene Plott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles D. Russell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Wheeler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiepu Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William E. Grizzle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Schlom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert F. LoBuglio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 37, Issue 9
September 1, 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Lutetium-177-CC49
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Lutetium-177-CC49
Ruby F. Meredith, Edward E. Partridge, Ronald D. Alvarez, M.B. Khazaeli, Gene Plott, Charles D. Russell, Richard H. Wheeler, Tiepu Liu, William E. Grizzle, Jeffrey Schlom, Albert F. LoBuglio
Journal of Nuclear Medicine Sep 1996, 37 (9) 1491-1496;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Lutetium-177-CC49
Ruby F. Meredith, Edward E. Partridge, Ronald D. Alvarez, M.B. Khazaeli, Gene Plott, Charles D. Russell, Richard H. Wheeler, Tiepu Liu, William E. Grizzle, Jeffrey Schlom, Albert F. LoBuglio
Journal of Nuclear Medicine Sep 1996, 37 (9) 1491-1496;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 177Lu-3BP-227 for Neurotensin Receptor 1-Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
  • Brief Intraperitoneal Radioimmunotherapy of Small Peritoneal Carcinomatosis Using High Activities of Noninternalizing 125I-Labeled Monoclonal Antibodies
  • Intraperitoneal {alpha}-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study
  • Targeted Actinium-225 in Vivo Generators for Therapy of Ovarian Cancer
  • A Novel Approach for the Increased Delivery of Pharmaceutical Agents to Peritoneum and Associated Lymph Nodes
  • A Phase I Study of Combined Modality 90Yttrium-CC49 Intraperitoneal Radioimmunotherapy for Ovarian Cancer
  • Improved Prediction of Myelotoxicity Using a Patient-Specific Imaging Dose Estimate for Non-Marrow-Targeting 90Y-Antibody Therapy
  • Targeted Therapy of Cancer with Radiolabeled Antibodies
  • Radioimmunotherapy of a Human Lung Cancer Xenograft with Monoclonal Antibody RS7: Evaluation of 177Lu and Comparison of Its Efficacy with That of 90Y and Residualizing 131I
  • Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro
  • Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only
  • Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity
  • In Vivo Localization of [111In]-DTPA-D-Phe -Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector
  • Google Scholar

More in this TOC Section

  • PET with L-[1-Carbon-11]-Tyro sine to Visualize Tumors and Measure Protein Synthesis Rates
  • Scintigraphic Assessment of Therapeutic Success in Aldosteronomas Treated by Transcatheter Arterial Embolization Using Absolute Ethanol
  • Incremental Prognostic Value of Thallium Reinjection after Stress-Redistribution Imaging in Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction
Show more Human Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire